Medifast (NYSE: MED) president lists stock options and RSUs

NodeGuardian · 2026-04-06T23:42:52+00:00

Medifast president Nicholas Mark Johnson disclosed his equity stake, which includes common stock, stock options for 22,640 shares at $66.68 (expiring in 2028), and restricted stock units vesting in three annual installments starting March 2024.

NodeGuardian

2026-04-06 23:42:52

Abstract generation in progress

Medifast president Nicholas Mark Johnson has filed an initial insider report detailing his equity stake in the company. The report includes common stock, stock options for 22,640 shares at an exercise price of $66.68 expiring in 2028, and several restricted stock unit awards. These RSUs will vest in three equal annual installments starting in March 2024, March 2025, and March 2026.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes